{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:54:10Z","timestamp":1790553250459,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajo.2021.03.017","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:05:09Z","timestamp":1616670309000},"page":"288-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis"],"prefix":"10.1016","volume":"229","author":[{"given":"Eugene B.","family":"McLaurin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Repke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-6439","authenticated-orcid":false,"given":"Erin","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nysha","family":"Blender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Q.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Vantipalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Metzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2021.03.017_bib0001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.2007.01583.x","article-title":"Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires","volume":"63","author":"Petersen","year":"2008","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0003","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3111\/13696998.2011.576039","article-title":"Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients\u2014an observational, cross sectional study in four countries in Europe","volume":"14","author":"Virchow","year":"2011","journal-title":"J Med Econ"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0004","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/112067211002000201","article-title":"Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life","volume":"20","author":"Palmares","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1824-7288-39-18","article-title":"Allergic conjunctivitis: a comprehensive review of the literature","volume":"39","author":"La Rosa","year":"2013","journal-title":"Ital J Pediatr"},{"issue":"1","key":"10.1016\/j.ajo.2021.03.017_bib0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.iac.2007.12.005","article-title":"Allergic conjunctivitis","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin N Am"},{"issue":"230","key":"10.1016\/j.ajo.2021.03.017_bib0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0420.2000.078s230041.x","article-title":"The early and late phase of the ocular allergic reaction","author":"Bonini","year":"2000","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2500\/ar.2016.7.0158","article-title":"Treating allergic conjunctivitis: a once\u2013daily medication that provides 24-hour symptom relief","volume":"7","author":"Carr","year":"2016","journal-title":"Allergy Rhinol (Providence)"},{"issue":"5","key":"10.1016\/j.ajo.2021.03.017_bib0009","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2500\/aap.2013.34.3695","article-title":"An algorithm for the management of allergic conjunctivitis","volume":"34","author":"Bielory","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0010","first-page":"78","article-title":"Topical corticosteroids and antihistamines\u2014mast cell stabilizers for the treatment of allergic conjunctivitis","volume":"6","author":"Gong","year":"2013","journal-title":"US Ophthalmic Rev"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ajo.2021.03.017_bib0012","unstructured":"Alocril [prescribing information]. Allergan; 2008."},{"key":"10.1016\/j.ajo.2021.03.017_bib0013","unstructured":"Alomide [prescribing information]. Alcon Laboratories; 2018."},{"key":"10.1016\/j.ajo.2021.03.017_bib0014","unstructured":"Bepreve [prescribing information]. Bausch\u202f+\u202fLomb; 2019."},{"key":"10.1016\/j.ajo.2021.03.017_bib0015","unstructured":"Cromolyn [prescribing information]. Bausch\u202f+\u202fLomb; 2016."},{"key":"10.1016\/j.ajo.2021.03.017_bib0016","unstructured":"Elestat [prescribing information]. Allergan; 2011."},{"key":"10.1016\/j.ajo.2021.03.017_bib0017","unstructured":"Lastacaft [prescribing information]. Allergan; 2015."},{"key":"10.1016\/j.ajo.2021.03.017_bib0018","unstructured":"Pataday [prescribing information]. Alcon Laboratories; 2010."},{"key":"10.1016\/j.ajo.2021.03.017_bib0019","unstructured":"Pataday Twice Daily Relief [prescribing information]. Alcon Laboratories; 2002."},{"key":"10.1016\/j.ajo.2021.03.017_bib0020","unstructured":"Pazeo [prescribing information]. Alcon Laboratories; 2016."},{"key":"10.1016\/j.ajo.2021.03.017_bib0021","unstructured":"Zerviate [prescribing information]. Eyevance Pharmaceuticals; 2020."},{"key":"10.1016\/j.ajo.2021.03.017_bib0022","first-page":"2131","article-title":"Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops","volume":"7","author":"Rosin","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2021.03.017_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.13055","article-title":"Recovery after cataract surgery","volume":"94","author":"Porela-Tiihonen","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.017_bib0024","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9570.1000572","article-title":"Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies","volume":"7","author":"Walters","year":"2016","journal-title":"J Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0025","unstructured":"American Academy of Ophthalmology. Conjunctivitis preferred practice pattern. Available at: https:\/\/www.aao.org\/preferred-practice-pattern\/conjunctivitis-ppp-2018. Accessed June 5, 2020."},{"issue":"5","key":"10.1016\/j.ajo.2021.03.017_bib0026","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/17469899.2015.1081563","article-title":"Challenges faced in clinical trials for chronic allergic conjunctivitis","volume":"10","author":"Gomes","year":"2015","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0027","unstructured":"DEXTENZA [prescribing information]. Ocular Therapeutix, Inc.; 2019."},{"issue":"11","key":"10.1016\/j.ajo.2021.03.017_bib0028","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40265-020-01344-6","article-title":"Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation [published correction appears in Drugs 2020 Jul 22]","volume":"80","author":"Lee","year":"2020","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0029","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","article-title":"Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery [published correction appears in J Cataract Refract Surg 2019 Jun;45(6):895]","volume":"45","author":"Tyson","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ajo.2021.03.017_bib0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0031","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2010.548797","article-title":"The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis","volume":"27","author":"Torkildsen","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajo.2021.03.017_bib0032","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2147\/OPTH.S185835","article-title":"Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model","volume":"12","author":"Meier","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0033","first-page":"1495","article-title":"Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%","volume":"8","author":"Bergmann","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0034","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ICL.0000000000000152","article-title":"A phase 2 exploratory study of a novel interleukin-1 receptor inhibitor (EBI-005) in the treatment of moderate-to-severe allergic conjunctivitis","volume":"41","author":"Goldstein","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.017_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425255.4.4.453","article-title":"Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing","volume":"4","author":"Abelson","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0036","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jop.2016.0154","article-title":"Vehicle-controlled, phase 2 clinical trial of a sustained-release dexamethasone intracanalicular insert in a chronic allergen challenge model","volume":"33","author":"Torkildsen","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.017_bib0037","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/jop.1998.14.533","article-title":"The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate","volume":"14","author":"Abelson","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ajo.2021.03.017_bib0038","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jcrs.2015.11.005","article-title":"Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery","volume":"41","author":"Walters","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2021.03.017_bib0039","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/OPTH.S150816","article-title":"Glaucoma therapy: preservative-free for all?","volume":"12","author":"Thygesen","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.017_bib0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2021.03.017_bib0041","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bjo.74.8.477","article-title":"A study of the cause of non-compliance by patients prescribed eyedrops","volume":"74","author":"Winfield","year":"1990","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2021.03.017_bib0042","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jcrs.2014.02.037","article-title":"Evaluation of eyedrop administration by inexperienced patients after cataract surgery","volume":"40","author":"An","year":"2014","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"10.1016\/j.ajo.2021.03.017_bib0043","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence: a cross-sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.017_bib0044","first-page":"29","article-title":"An evaluation of how glaucoma patients use topical medications: a pilot study","volume":"105","author":"Tsai","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"10","key":"10.1016\/j.ajo.2021.03.017_bib0045","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4103\/ijo.IJO_2143_18","article-title":"Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: an important public health problem in pediatric age group","volume":"67","author":"Sen","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.017_bib0046","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0047","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","article-title":"Ocular effects of topical and systemic steroids","volume":"10","author":"Renfro","year":"1992","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ajo.2021.03.017_bib0048","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jfo.2011.12.012","article-title":"Epidemiological aspects of keratoconus in children [article in French]","volume":"35","author":"L\u00e9oni-Mespli\u00e9","year":"2012","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"10.1016\/j.ajo.2021.03.017_bib0049","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.18240\/ijo.2019.11.17","article-title":"The correlation between keratoconus and eye rubbing: a review","volume":"12","author":"Najmi","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0050","unstructured":"American Academy of Ophthalmology. Corneal ectasia preferred practice pattern. Available at: https:\/\/www.aao.org\/preferred-practice-pattern\/corneal-ectasia-ppp-2018. Accessed June 5, 2020."},{"issue":"8","key":"10.1016\/j.ajo.2021.03.017_bib0051","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0301-4738.116062","article-title":"Acute corneal hydrops in keratoconus","volume":"61","author":"Maharana","year":"2013","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.017_bib0052","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","article-title":"Allergic conjunctivitis and dry eye syndrome","volume":"108","author":"Hom","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2021.03.017_bib0053","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000471","article-title":"Ocular allergy as a risk factor for dry eye in adults and children","volume":"18","author":"Villani","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ajo.2021.03.017_bib0054","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S38732","article-title":"Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy","volume":"7","author":"Gomes","year":"2013","journal-title":"Clin Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:44:00Z","timestamp":1762080240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421001306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":54,"alternative-id":["S0002939421001306"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}